Raydn Back to the front page ◐ StockAMGNAmgen440.30-1.56%at the closePrice as of Saturday, October 24, 2026 at 12:26 PM ETRaydn storiesOct 24, 10:39 AM ETAmgen says Imdelltra plus durvalumab extends survival in lung cancer trial